Cassava Sciences Reports Q1 2024 Financial Results and Clinical Updates on Phase 3 Trials of Simufilam
GlobeNewswire
· *$126.3 Million In Total Gross Proceeds from Warrant Distribution.
*
· *Over 1,900 Patients with Alzheimer’s..
· *$126.3 Million In Total Gross Proceeds from Warrant Distribution.
*
· *Over 1,900 Patients with Alzheimer’s..
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Edge Artificial Intelligence Global Market Report 2024" report has been added to *..
Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "Ethical Fashion Global Market Report 2024" report has been added to *..